International Biotechnology (LON:IBT) Shares Pass Above 200-Day Moving Average - Here's Why

Key Points

• Shares passed above its 200-day moving average (200‑day MA GBX 920.68), trading as high as GBX 968 and last at GBX 944 on a volume of 74,124 shares.
• Market capitalization stands at £301.16 million with a negative P/E of -286.93 and a low beta of 0.49, indicating limited historical volatility despite unprofitable earnings.
• Investment objective: the trust seeks long-term capital growth by investing in a diversified portfolio of biotechnology and related life‑sciences companies, both quoted and unquoted.

Shares of International Biotechnology (LON:IBT - ) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 920.68 and traded as high as GBX 968. International Biotechnology shares last traded at GBX 944, with a volume of 74,124 shares traded.

International Biotechnology Price Performance

The business has a 50-day moving average of GBX 923.69 and a 200 day moving average of GBX 920.68. The company has a market capitalization of £301.16 million, a PE ratio of -286.93 and a beta of 0.49.

International Biotechnology Company Profile

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.